Intervention Review

Zuclopenthixol dihydrochloride for schizophrenia

  1. Ajit Kumar1,*,
  2. Daniel Strech2

Editorial Group: Cochrane Schizophrenia Group

Published Online: 19 OCT 2005

Assessed as up-to-date: 10 JUL 2005

DOI: 10.1002/14651858.CD005474

How to Cite

Kumar A, Strech D. Zuclopenthixol dihydrochloride for schizophrenia. Cochrane Database of Systematic Reviews 2005, Issue 4. Art. No.: CD005474. DOI: 10.1002/14651858.CD005474.

Author Information

  1. 1

    Leeds and York Partnership NHS Foundation Trust, Psychiatry, Leeds, UK

  2. 2

    Charité - Universitätsmedizin Berlin, Department of Psychiatry and Psychotherapy, Berlin, Germany

*Ajit Kumar, Psychiatry, Leeds and York Partnership NHS Foundation Trust, Linden House, St Mary's Hospital, Green Hill Road, Leeds, LS12 3QE, UK.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 19 OCT 2005


Cited in:


This article has been cited by:

  1. 1
    Michael Lacey, Mahesh B Jayaram, Christine Esbensen, Zuclopenthixol versus placebo for schizophrenia, The Cochrane Library,